Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI)

CUSIP: 753018100

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Class A Common Stock, Par Value $.0001
Shares outstanding
98,437,808
Total 13F shares
5,911,071
Share change
+2,802,596
Total reported value
$12,767,865
Put/Call ratio
88%
Price per share
$2.16
Number of holders
31
Value change
+$5,999,502
Number of buys
12
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 753018100?
CUSIP 753018100 identifies RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI) as of Q3 2024

As of 30 Sep 2024, Rani Therapeutics Holdings, Inc. - Class A Common Stock, Par Value $.0001 (RANI) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,911,071 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, Nan Fung Group Holdings Ltd, Alphabet Inc., UNITED SERVICES AUTOMOBILE ASSOCIATION, STIFEL FINANCIAL CORP, TAKEDA PHARMACEUTICAL CO LTD, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and KING LUTHER CAPITAL MANAGEMENT CORP. This page lists 31 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.